Clinical Report: Adding CRP to CAD-guided TB screening offers no benefit
Overview
A study comparing CAD-guided chest x-ray screening with and without CRP testing found that the CAD-only strategy detected more tuberculosis cases at a lower cost. The CAD-plus-CRP strategy did not demonstrate noninferiority and was 37% more expensive per case detected.
Background
Tuberculosis (TB) remains a significant global health challenge, particularly in resource-limited settings. Effective screening strategies are essential for early detection and treatment to reduce TB transmission. This study evaluates the cost-effectiveness and diagnostic performance of adding C-reactive protein (CRP) testing to a CAD-guided screening approach.
Data Highlights
| Screening Strategy | TB Cases Detected | Cost per Case Detected |
|---|---|---|
| CAD Only | 69 | $5,454 |
| CAD + CRP | 60 | $7,486 |
Key Findings
- The CAD-only strategy identified 94.5% of TB cases compared to 82.2% for CAD plus CRP.
- The CAD-plus-CRP strategy was 37% more expensive per TB case detected.
- Thirteen TB cases were identified exclusively by CAD alone, compared to four by CAD plus CRP.
- 46% of participants with confirmed TB had none of the four main TB symptoms.
- Noninferiority of the CAD-plus-CRP strategy was not demonstrated, as the lower bound of the 95% CI extended below the -10% margin.
Clinical Implications
The findings indicate that adding CRP testing to CAD-guided TB screening does not improve case detection and increases costs.
Conclusion
The study indicates that the CAD-plus-CRP strategy did not demonstrate noninferiority compared to CAD alone.
Related Resources & Content
- The Lancet Infectious Diseases, 2024 -- Community-based tuberculosis screening with computer-aided detection technology alone and in combination with point-of-care C-reactive protein testing: a paired screen-positive trial
- Frontiers in Digital Health — Beyond accuracy: evaluating the operational feasibility and diagnostic yield of CAD4TB vs. Timika score for scalable TB screening in low-resource settings
- Is MRI Essential for All Patients Without Prior Biopsy? Insights from a Multicenter Cohort Study
- The ASCO Post — Addition of Ultrasound to DBT for Breast Cancer Screening in Patients With Dense Breasts
- the pathologist — Tuberculosis Screening Accuracy Boosted
- Executive summary - WHO consolidated guidelines on tuberculosis
- Recommendations - WHO consolidated guidelines on tuberculosis
- Community-based tuberculosis screening with computer-aided detection technology alone and in combination with point-of-care C-reactive protein testing: a paired screen-positive trial - ScienceDirect
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
